Skip to main content
SpringerLink
Log in

Kommunikation zwischen Arzt und Patient im Fokus

Neues von internationalen Asthma-Leitlinien 2014

  • fortbildung
  • Published:
Pneumo News Aims and scope

International hat sich in der letzten Zeit einiges getan, was die Empfehlungen zum Management bei Asthma bronchiale betrifft. Die European Respiratory Society und die American Thoracic Society haben gemeinsam einen Taskforce-Bericht mit Empfehlungen zum schweren Asthma herausgebracht. Die Global Initiative for Asthma hat ebenfalls ein Update publiziert. Enthalten sind darin viele für die Praxis relevante Aspekte. Hier bekommen Sie einen Überblick.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

1

Literatur

  1. Buhl R, Berdel D, Criee C-P, Gillissen A et al. Leitlinie zur Diagnostik und Therapie von Patienten mit Asthma der Deutschen Atemwegsliga und der Deutschen Gesellschaft für Pneumologie und Beatmungsmedizin e.V. Pneumologie 2006; 60:139–83

    Article  PubMed  CAS  Google Scholar 

  2. Ärztliches Zentrum für Qualität in der Medizin (ÄZQ). Nationale Versorgungsleitlinie Asthma. www.leitlinien.de 2009

  3. GINA Executive and Science Committee (Hrsg). Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention.2014; www.ginasthma.org/local/uploads/files/GINA_Report_2014_Jun11.pdf

  4. Chung K F, Wenzel S E, Brozek J L, Bush A et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur.Respir.J. 2014; 43:343–73

    Article  PubMed  CAS  Google Scholar 

  5. Baur X, Sigsgaard T, Aasen T B et al. Guidelines for the management of work-related asthma. Eur.Respir.J. 2012; 39:529–45

    Article  PubMed  CAS  Google Scholar 

  6. Gillissen A, Juergens U R, Büsch K. Therapieaadhärenz bei Asthma bronchiale. Methoden zur Verbesserung. Dtsch.Med.Wschr. 2008; 133:1451–56

    Article  PubMed  CAS  Google Scholar 

  7. Gerbase M W, Schindler C, Zellweger J P et al. Respiratory effects of environmental tobacco exposure are enhanced by bronchial hyperreactivity. Am.J.Respir.Crit.Care Med. 2008; 174:1125–31

    Article  Google Scholar 

  8. ten Brinke A. Risk factors associated with irreversie airflow limitation in asthma. Curr.Opin.Allerg.Clin.Immunol. 2008;8:63–9

    Article  Google Scholar 

  9. Braido F. Failure in asthma control: reasons and consequences. Scientifica.(Cairo.) 2013; 2013:549252

    Google Scholar 

  10. Gillissen A, Worth H. Asthma in der Schwangerschaft. Dtsch.Med.Wschr. 2008;133:1977–80

    Article  PubMed  CAS  Google Scholar 

  11. Cazzoletti L, Corsico A G, Albicini F et al. The course of asthma in young adults: a population-based nine-year follow-up on asthma remission and control. PLoS.One. 2014; 9:e86956

    Article  PubMed  PubMed Central  Google Scholar 

  12. Roberts N J, Robinson D S, Partridge M R. How is difficult asthma managed? Eur.Respir.J. 2006;28:968–73

    Article  PubMed  CAS  Google Scholar 

  13. Dweik R A, Sorkness R L, Wenzel S, Hammel J et al. Use of exhaled nitric oxide measurement to identify a reactiv, at-risk phenotype among patients with asthma. Am.J.Respir.Crit.Care Med. 2010; 181:1033–41

    Article  PubMed  CAS  PubMed Central  Google Scholar 

  14. Baur X, Barbinova L. Messung von exhaliertem Stickstoffmonoxid. Klinischer Einsatz bei Atemwegserkrankungen. Dt.Ärztebl. 2009; 104:A790–A796

    Google Scholar 

  15. Gillissen A. Patient adherence in asthma. J.Physiol.Pharmacol. 2007; 58:205–22

    Google Scholar 

  16. Navaratnam P, Jayawant S S, Pedersen C A, et al. Physician adherence to the national asthma prescribing guidelines: evidence from national outpatient survey data in United States. Ann.Allergy Asthma Immunol. 2008; 100:216–21

    Article  PubMed  Google Scholar 

  17. Gibson P G, Simpson J L. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64:728–35

    Article  PubMed  CAS  Google Scholar 

  18. Wahidi M M, Kraft M. Bronchial thermoplasty for severe asthma. Am.J.Respir.Crit.Care Med. 2012; 185:709–14

    Article  PubMed  Google Scholar 

  19. Chung K F. Defining phenotypes in asthma: a step towards personalized medicine. Drugs 2014; 74:719–28

    Article  PubMed  CAS  Google Scholar 

  20. Quirce S, Bobolea I, Dominguez-Ortega J et al. Future Biologic Therapies in Asthma. Arch.Bronconeumol. 2014; 50:355–61

    Article  PubMed  Google Scholar 

  21. Clienti S, Morjaria J B, Basile E et al. Monoclonal antibodies for the treatment of severe asthma. Curr.Allergy Asthma Rep. 2011;11:253–60

    Article  PubMed  CAS  Google Scholar 

  22. Holgate S T, Chuchalin A, Herbert J et al. Omalizumab, a novel therapy for severe allergic asthma. Eur.Respir.J. 2001; 8:37s

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Klinik für Lungen- und Bronchialmedizin, Klinikum Kassel, Kassel School of Medicine, Mönchebergstr. 41–43, 34125, Kassel, Deutschland

    Adrian Gillissen

Authors
  1. Adrian Gillissen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Adrian Gillissen.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Gillissen, A. Kommunikation zwischen Arzt und Patient im Fokus. Pneumo News 6, 45–48 (2014). https://doi.org/10.1007/s15033-014-0027-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s15033-014-0027-1

Search

Navigation